Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

There is currently no vaccine available ... omicron variant XEC rising as a fast-spreading variant slated to take over as the ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The latest coronavirus strain, XEC, makes up 17%. It is another descendant from the ... insurance provider as we cannot ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

The Centers for Disease Control and Prevention updated its COVID-19 vaccine recommendations for those over 65 and people who are immunocompromised. Older adults and people who are ...

1, KP.3.1.1 and XEC spike proteins, although the responses to the latter ... Official CDC guidance is that everyone 6 months ...

A new COVID-19 variant called XEC is spreading around the world, as numerous countries deal with another flu season. The strain, which is a combination of Omicron subvariants KS.1.1 and KP.3.3 ...

The swift emergence of the new Covid variant XEC, which experts worry may outmanoeuvre ... while Novavax's current vaccine targets the older JN. 1 strain. Dr Roberts suggests a mix-and-match ...